# Asunaprevir/Daclatasvir Safety Surveillance in Japanese Patients With Chronic Hepatitis C

> **NCT02250001** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 2974 (actual)

## Conditions studied

- Chronic Hepatitis C

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02250001
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09-30
- **Primary completion:** 2017-01-20
- **Final completion:** 2017-01-20
- **Target enrollment:** 2974 (ACTUAL)
- **Last updated:** 2017-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02250001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02250001, "Asunaprevir/Daclatasvir Safety Surveillance in Japanese Patients With Chronic Hepatitis C". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02250001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*